After proteomics and genomics, lipidomics promises to be the next emerging field of research in the bioscience industry....
Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials...
Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million...
Singapore: Globally, the healthcare industry is in a state of accelerated evolution due to changing demographics and var...
Reforms in government policies and initiatives have helped in setting focus for bioscience companies, which has resulted...
New Zealand Trade and Enterprise (NZTE) is New Zealand government's national economic development agency and works to st...
Singapore: Russia-based Pharmstandard revealed the key terms of a probable acquisition of 100 percent share capital of S...
Singapore: Interphex Asia, a platform for pharmaceutical and biopharmaceutical technologies, services, innovations, and ...
Singapore: TauRx Therapeutics, which is headquartered in Singapore, has initiated a global phase III clinical trial in a...
Singapore: The pharmaceutical unit of the Jubilant Bhartia Group will soon be listed on an overseas stock exchange, maki...
Singapore: Scientists at the Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore (GIS)...
Singapore: Following successful first-in-man phase I and two phase IIa clinical studies with the oral formulation of fin...
Singapore: In a latest boost to A*STAR's collaborations with the industry, Dr Bing Lim, associate director, cancer stem ...
Integration of information and technology (IT) in healthcare services and translating the potential into better delivery...
Singapore: Hitachi Asia and Data Storage Institute (DSI), a research institute of the Agency for Science, Technology and...
Singapore: NeuroAiD, a stroke treatment, developed by Singapore firm Moleac, based on Traditional Chinese Medicine, incr...
Singapore: Researchers from the Agency for Science, Technology and Research (A*STAR) have developed cutting-edge telehea...
Singapore: In response to the growing demand for eye drugs in Asia, Novartis subsidiary Alcon, has opened a new $160m fa...
